The IL-6 family of proteins has a bad reputation: it can promote inflammation, arthritis, autoimmune disease and even cancer. However, a new USC-led study published in Communications Biology reveals the importance of IL-6 ...
Jan 17, 2022
0
82
New findings provide a better understanding of how the synthesis of dopamine is regulated in the brain. It may shed new light on the mechanism behind diseases such as Parkinson's.
Jan 12, 2022
0
155
A study published today in Cell Reports reveals important insights into the molecular mechanisms that underpin the body's natural defenses against the development of skin cancer. The findings offer new clues into the behavior ...
Jan 11, 2022
0
72
A new cancer study reports that DNA manifested as knot-like folds and third rungs between DNA's two strands may drive cancer development, and an important regulatory enzyme could be associated with the formation of these ...
Jan 3, 2022
0
180
UBC researchers are the first in the world to conduct a molecular-level structural analysis of the omicron variant spike protein.
Dec 23, 2021
0
230
Depression is a global issue. The World Health Organization (WHO) estimates that 15 percent of people will experience a disabling bout of depression at some point in their lives. Despite an array of treatments that includes ...
Nov 26, 2021
0
109
Processing of sensory impressions and information depends very much on how the synapses in our brain work. A team around chemist Robert Ahrends from the University of Vienna and neuroscientist Michael R. Kreutz from Leibniz ...
Oct 20, 2021
0
117
Alzheimer's disease (AD) is a neurological condition leading to dementia that worsens with age as patients exhibit cognitive, memory, and psychological deficits. While current therapies focus on relieving these symptoms to ...
Aug 5, 2021
1
201
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
Jul 8, 2021
2
25
Amyloid diseases, including Alzheimer's, Parkinson's, type-2 diabetes and other life-threatening diseases, involve pathologic deposits of normally soluble proteins or peptides as insoluble amyloid fibrils. When this happens ...
Jun 28, 2021
0
2
